VERA

Vera TherapeuticsC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

VERA vs peer average

46/100

VERA vs. peer average (C vs. C)

Grade spread

B 6 · C 3 · D 1 · F 1

Graded peers loaded

Coverage

11 graded

92% of tracked

Peer overview

APLS is the first available peer comparator.

Apellis Pharmaceuticals — immunology/rare-disease focus; relevant for licensing, reimbursement dynamics and valuation swings tied to clinical readouts.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAPLS

VERA

Vera Therapeutics

APLS

Peer

Grade

Momentum

Value

Sentiment

100

Setup Bias

Net Neutral

Market Cap

Posture

Mixed

Unrated

Open Side-by-Side Comparison Compare all

Grade position vs APLS

VERA / APLS

Grade Position

In line

VERA vs. peer average (C vs. C)

46/100

Momentum

Value

Sentiment

100

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs VERA

APLS

ARQT

60/100

Even

IDYA

80/100

-1

VCYT

80/100

-1

CLDX

Celldex Therapeutics Inc Common

60/100

Even

APLS is the first peer returned for this comparison set.